2016
DOI: 10.1016/j.jdcr.2016.08.010
|View full text |Cite
|
Sign up to set email alerts
|

Cutaneous metastases from adenocarcinoma of the ovary

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
7
0

Year Published

2018
2018
2022
2022

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(10 citation statements)
references
References 6 publications
(10 reference statements)
0
7
0
Order By: Relevance
“…They can occur with the direct spread of malignant cells within the abdominal cavity or via lymphatic vessels (13). Although pleura, liver, bone, lung, and lymph nodes are common sites of distant metastasis, cutaneous metastases are rare in ovarian malignancies (10). Nowadays the main treatment for advanced stages of dysgerminoma, eg, disease with extra-ovarian spread, is post-operative adjuvant chemotherapy with carboplatin or cisplatin in combination with etoposide and bleomycin (14).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…They can occur with the direct spread of malignant cells within the abdominal cavity or via lymphatic vessels (13). Although pleura, liver, bone, lung, and lymph nodes are common sites of distant metastasis, cutaneous metastases are rare in ovarian malignancies (10). Nowadays the main treatment for advanced stages of dysgerminoma, eg, disease with extra-ovarian spread, is post-operative adjuvant chemotherapy with carboplatin or cisplatin in combination with etoposide and bleomycin (14).…”
Section: Discussionmentioning
confidence: 99%
“…Magnetic Resonance Imaging (MRI) could help distinguish these, though pathologic specimens are essential for ultimate diagnosis (9). The most common ovarian tumor which metastasizes to the skin is epithelial adenocarcinoma (serous, mucinous, and endometrioid) (10). Dysgerminoma is the most common ovarian germ cell tumor that may have a local invasion, lymphatic spread to pelvic lymph nodes, or hematogenous metastases (11).…”
Section: Introductionmentioning
confidence: 99%
“…Cutaneous metastases are estimated to occur in 2% to 5% of patients with ovarian tumors, and portend a poor prognosis. [85][86][87] In one series, the most commonly reported ovarian variant to metastasize was serous papillary cystadenocarcinoma (78%), followed by endometrioid and mucinous variants. 85 Clinically, the majority of patients present with crops of multiple erythematous nodules involving the chest or abdomen, with multiple reports of seeding occurring in laparotomy scars or trocar port sites.…”
Section: Gynecologicmentioning
confidence: 99%
“…Cutaneous metastasis is an uncommon manifestation of internal malignancy, occurring in 0.9% to 5.8% of patients with ovarian carcinoma [5][6][7]. Up to this date, to the best of our knowledge, there is no report of PPCCC with cutaneous metastasis.…”
Section: Introductionmentioning
confidence: 96%